How-to

Sites and Investigators Are Still Number One, or Are They Really?

It’s been a long weekend and I had more time to think about the things in LIFE. I have been thinking lately about how balance in nature is the only thing which is certain. Everything around us (including political craziness around the Globe these days) can be explained with the world trying to find a …

Sites and Investigators Are Still Number One, or Are They Really? Read More »

The 3 Main Limitations To Public Clinical Trial Registers (And Why They’re Still The Go-To for Feasibility)

Public clinical trial registers were designed to comply with regulations (and make the public aware of past, ongoing, and future clinical trials), not for the purposes of clinical trial feasibility. This becomes abundantly clear once you try to gather the data you need for site selection or calculate recruitment rate for multiple sites in multiple …

The 3 Main Limitations To Public Clinical Trial Registers (And Why They’re Still The Go-To for Feasibility) Read More »

All the Challenges in Clinical Research, Are First Such in Healthcare

I was busy lately speaking to people and working on projects to help companies adapt to the “new normal” and find out what this means. It turned out that this time helped me to go outside of my “normal” and see a few mistakes that I have been doing over the last few years.  Number …

All the Challenges in Clinical Research, Are First Such in Healthcare Read More »

8 Mysteries About Remote Clinical Trials Revealed

Two weeks ago I was invited to speak at the Festival of Biologics in Basel, Switzerland. As a part of their Clinical Trials Conference, I was speaking about the ways we can measure whether patients find your clinical trial attractive. I also hosted a round table about “Remote Clinical Trials”. A lot of people joined me to …

8 Mysteries About Remote Clinical Trials Revealed Read More »

What Stops Patient Engagement in Clinical Trials

Last week I was invited to speak at Bayer’s Headquarters during their Annual Patient Engagement Meetup. This year I was attending a lot of other similar events thanks to our collaboration with different companies like Boehringer Ingelheim, Merck, Novartis, etc. And the last one really reminded me of: What Stops Patient Engagement in Clinical Research? …

What Stops Patient Engagement in Clinical Trials Read More »

We interviewed 50+ feasibility experts about their best practices

Since the launch of our feasibility and patient intelligence platform TrialHub, my team and I have spent hundreds of hours with feasibility teams worldwide to understand how they structure their processes and to make them more scalable and time-saving. I feel blessed I have been able to work with world-class experts trying to solve clinical …

We interviewed 50+ feasibility experts about their best practices Read More »

Patients and Clinical Trials: TRUST is what we need the most

The past few months were a challenge for everyone. Yet, the fear that patients felt due to the COVID-19 treat is indescribable. The high-risk patients were faced with multiple dilemmas like: Should I go and see my doctor for a regular check-up? How am I supposed to get my medicines prescribed? My parents are both …

Patients and Clinical Trials: TRUST is what we need the most Read More »

How to move to virtual clinical trials during Covid-19 (Part 3)

Part 1 | Part 2 Engage with participants Far from creating a sense of remoteness, virtual trials can prevent patients from feeling isolated by creating more timely and personalized touchpoints. Fortunately, existing technologies have paved the way to more engaging interactions with patients and assessment of their overall health and safety. When going virtual, ensure …

How to move to virtual clinical trials during Covid-19 (Part 3) Read More »

How to move to virtual clinical trials during Covid-19 (Part 2)

Return to Part 1 Protect participants and study staff Consider minimizing exposure for study participants and reducing in-person appointments that would require the participant to engage in non-essential travel. Many elements of the study visits can be supported with virtual technologies such as remote monitoring. Patients that are chronically or critically ill and at risk …

How to move to virtual clinical trials during Covid-19 (Part 2) Read More »

How to move to virtual clinical trials during Covid-19 (Part 1)

The majority of clinical trials worldwide are conducted in hospitals or major research institutions, mainly in the bigger cities. This prevents people who live hours away from having the opportunity to take part. Accessibility creates problems for people whose condition doesn’t let them travel or drive or those who are working or having family responsibilities. …

How to move to virtual clinical trials during Covid-19 (Part 1) Read More »